Report Detail
COVID-19 Impact on Global Subcutaneous Drug Delivery Devices Market Insights, Forecast to 2026
- RnM4016781 |
- 08 June, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Medical Devices & Consumables
Subcutaneous Drug Delivery Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Subcutaneous Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Subcutaneous Drug Delivery Devices market is segmented into
Prefilled Injectable
Filled Injectable
Segment by Application, the Subcutaneous Drug Delivery Devices market is segmented into
Hospitals
Clinics
Others
Regional and Country-level Analysis
The Subcutaneous Drug Delivery Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Subcutaneous Drug Delivery Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Subcutaneous Drug Delivery Devices Market Share Analysis
Subcutaneous Drug Delivery Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Subcutaneous Drug Delivery Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Subcutaneous Drug Delivery Devices business, the date to enter into the Subcutaneous Drug Delivery Devices market, Subcutaneous Drug Delivery Devices product introduction, recent developments, etc.
The major vendors covered:
BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc
Ypsomed AG
Elcam Medical
Amgen
1 Study Coverage
- 1.1 Subcutaneous Drug Delivery Devices Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Subcutaneous Drug Delivery Devices Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Subcutaneous Drug Delivery Devices Market Size Growth Rate by Type
- 1.4.2 Prefilled Injectable
- 1.4.3 Filled Injectable
- 1.5 Market by Application
- 1.5.1 Global Subcutaneous Drug Delivery Devices Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Subcutaneous Drug Delivery Devices Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Subcutaneous Drug Delivery Devices Industry
- 1.6.1.1 Subcutaneous Drug Delivery Devices Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Subcutaneous Drug Delivery Devices Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Subcutaneous Drug Delivery Devices Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Subcutaneous Drug Delivery Devices Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Subcutaneous Drug Delivery Devices Market Size Estimates and Forecasts
- 2.1.1 Global Subcutaneous Drug Delivery Devices Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Subcutaneous Drug Delivery Devices Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Subcutaneous Drug Delivery Devices Production Estimates and Forecasts 2015-2026
- 2.2 Global Subcutaneous Drug Delivery Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Subcutaneous Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Subcutaneous Drug Delivery Devices Manufacturers Geographical Distribution
- 2.4 Key Trends for Subcutaneous Drug Delivery Devices Markets & Products
- 2.5 Primary Interviews with Key Subcutaneous Drug Delivery Devices Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Subcutaneous Drug Delivery Devices Manufacturers by Production Capacity
- 3.1.1 Global Top Subcutaneous Drug Delivery Devices Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Subcutaneous Drug Delivery Devices Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Subcutaneous Drug Delivery Devices Manufacturers Market Share by Production
- 3.2 Global Top Subcutaneous Drug Delivery Devices Manufacturers by Revenue
- 3.2.1 Global Top Subcutaneous Drug Delivery Devices Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Subcutaneous Drug Delivery Devices Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Drug Delivery Devices Revenue in 2019
- 3.3 Global Subcutaneous Drug Delivery Devices Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Subcutaneous Drug Delivery Devices Production by Regions
- 4.1 Global Subcutaneous Drug Delivery Devices Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Subcutaneous Drug Delivery Devices Regions by Production (2015-2020)
- 4.1.2 Global Top Subcutaneous Drug Delivery Devices Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Subcutaneous Drug Delivery Devices Production (2015-2020)
- 4.2.2 North America Subcutaneous Drug Delivery Devices Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Subcutaneous Drug Delivery Devices Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Subcutaneous Drug Delivery Devices Production (2015-2020)
- 4.3.2 Europe Subcutaneous Drug Delivery Devices Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Subcutaneous Drug Delivery Devices Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Subcutaneous Drug Delivery Devices Production (2015-2020)
- 4.4.2 China Subcutaneous Drug Delivery Devices Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Subcutaneous Drug Delivery Devices Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Subcutaneous Drug Delivery Devices Production (2015-2020)
- 4.5.2 Japan Subcutaneous Drug Delivery Devices Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Subcutaneous Drug Delivery Devices Import & Export (2015-2020)
5 Subcutaneous Drug Delivery Devices Consumption by Region
- 5.1 Global Top Subcutaneous Drug Delivery Devices Regions by Consumption
- 5.1.1 Global Top Subcutaneous Drug Delivery Devices Regions by Consumption (2015-2020)
- 5.1.2 Global Top Subcutaneous Drug Delivery Devices Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Subcutaneous Drug Delivery Devices Consumption by Application
- 5.2.2 North America Subcutaneous Drug Delivery Devices Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Subcutaneous Drug Delivery Devices Consumption by Application
- 5.3.2 Europe Subcutaneous Drug Delivery Devices Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Subcutaneous Drug Delivery Devices Consumption by Application
- 5.4.2 Asia Pacific Subcutaneous Drug Delivery Devices Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Subcutaneous Drug Delivery Devices Consumption by Application
- 5.5.2 Central & South America Subcutaneous Drug Delivery Devices Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Subcutaneous Drug Delivery Devices Consumption by Application
- 5.6.2 Middle East and Africa Subcutaneous Drug Delivery Devices Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Subcutaneous Drug Delivery Devices Market Size by Type (2015-2020)
- 6.1.1 Global Subcutaneous Drug Delivery Devices Production by Type (2015-2020)
- 6.1.2 Global Subcutaneous Drug Delivery Devices Revenue by Type (2015-2020)
- 6.1.3 Subcutaneous Drug Delivery Devices Price by Type (2015-2020)
- 6.2 Global Subcutaneous Drug Delivery Devices Market Forecast by Type (2021-2026)
- 6.2.1 Global Subcutaneous Drug Delivery Devices Production Forecast by Type (2021-2026)
- 6.2.2 Global Subcutaneous Drug Delivery Devices Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Subcutaneous Drug Delivery Devices Price Forecast by Type (2021-2026)
- 6.3 Global Subcutaneous Drug Delivery Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Subcutaneous Drug Delivery Devices Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Subcutaneous Drug Delivery Devices Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 BD
- 8.1.1 BD Corporation Information
- 8.1.2 BD Overview and Its Total Revenue
- 8.1.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 BD Product Description
- 8.1.5 BD Recent Development
- 8.2 Insulet Corporation
- 8.2.1 Insulet Corporation Corporation Information
- 8.2.2 Insulet Corporation Overview and Its Total Revenue
- 8.2.3 Insulet Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 Insulet Corporation Product Description
- 8.2.5 Insulet Corporation Recent Development
- 8.3 Enable Injections
- 8.3.1 Enable Injections Corporation Information
- 8.3.2 Enable Injections Overview and Its Total Revenue
- 8.3.3 Enable Injections Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 Enable Injections Product Description
- 8.3.5 Enable Injections Recent Development
- 8.4 West Pharmaceutical Services, Inc
- 8.4.1 West Pharmaceutical Services, Inc Corporation Information
- 8.4.2 West Pharmaceutical Services, Inc Overview and Its Total Revenue
- 8.4.3 West Pharmaceutical Services, Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 West Pharmaceutical Services, Inc Product Description
- 8.4.5 West Pharmaceutical Services, Inc Recent Development
- 8.5 Ypsomed AG
- 8.5.1 Ypsomed AG Corporation Information
- 8.5.2 Ypsomed AG Overview and Its Total Revenue
- 8.5.3 Ypsomed AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Ypsomed AG Product Description
- 8.5.5 Ypsomed AG Recent Development
- 8.6 Elcam Medical
- 8.6.1 Elcam Medical Corporation Information
- 8.6.2 Elcam Medical Overview and Its Total Revenue
- 8.6.3 Elcam Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 Elcam Medical Product Description
- 8.6.5 Elcam Medical Recent Development
- 8.7 Amgen
- 8.7.1 Amgen Corporation Information
- 8.7.2 Amgen Overview and Its Total Revenue
- 8.7.3 Amgen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 Amgen Product Description
- 8.7.5 Amgen Recent Development
- 8.8 Wilhelm Haselmeier
- 8.8.1 Wilhelm Haselmeier Corporation Information
- 8.8.2 Wilhelm Haselmeier Overview and Its Total Revenue
- 8.8.3 Wilhelm Haselmeier Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 Wilhelm Haselmeier Product Description
- 8.8.5 Wilhelm Haselmeier Recent Development
9 Production Forecasts by Regions
- 9.1 Global Top Subcutaneous Drug Delivery Devices Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Subcutaneous Drug Delivery Devices Regions Forecast by Production (2021-2026)
- 9.3 Key Subcutaneous Drug Delivery Devices Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Subcutaneous Drug Delivery Devices Consumption Forecast by Region
- 10.1 Global Subcutaneous Drug Delivery Devices Consumption Forecast by Region (2021-2026)
- 10.2 North America Subcutaneous Drug Delivery Devices Consumption Forecast by Region (2021-2026)
- 10.3 Europe Subcutaneous Drug Delivery Devices Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Subcutaneous Drug Delivery Devices Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Subcutaneous Drug Delivery Devices Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Subcutaneous Drug Delivery Devices Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Subcutaneous Drug Delivery Devices Sales Channels
- 11.2.2 Subcutaneous Drug Delivery Devices Distributors
- 11.3 Subcutaneous Drug Delivery Devices Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Market Opportunities and Drivers
- 12.2 Market Challenges
- 12.3 Market Risks/Restraints
- 12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Subcutaneous Drug Delivery Devices Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Subcutaneous Drug Delivery Devices. Industry analysis & Market Report on COVID-19 Impact on Global Subcutaneous Drug Delivery Devices is a syndicated market report, published as COVID-19 Impact on Global Subcutaneous Drug Delivery Devices Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Subcutaneous Drug Delivery Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
